Comparing the effect of Varenicline tablet with correction of attention bias in smoking cessatio

Not Applicable

Recruiting

• Conditions: icotine dependence.; Nicotine dependence, cigarettes; F17.21

• Registration Number: IRCT20181026041468N3
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Smokers at the age of 18-60
Having a minimum literacy
Informed consent

Exclusion Criteria

Request from the patient or the patient's legal guardian to leave the study at any time of the study
Occurrence of harmful or intrusive side effects due to Varenicline or attention bias
Severe smoker

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Smoke cessation. Timepoint: Beginning ?middle and the end of the intervention. Method of measurement: Nicotine dependence scale (NDSS).